Related Experiment Video
Updated: Jul 11, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma
Toru Tateno1, Hajime Izumiyama, Masaru Doi
1Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Japan.
Abstract:
Silent corticotroph adenoma (SCA) is defined as an ACTH-producing pituitary tumor not associated with clinical and endocrine feartures of Cushing's syndrome, but its underlying molecular mechanism(s) remains unknown thus far. We tested the hypothesis that reduced expression of prohormone convertase (PC) 1/3 responsible for proteolytic processing of proopiomelanocortin (POMC) in SCA may lead to production of unprocessed, biologically inactive POMC and/or precursor of ACTH. Among 30 non-functioning pituitary macroadenomas (NFA) examined, we found 6 SCAs by immunohistochemical study using anti-ACTH antibody. Preoperative endocrine and diagnostic image tests did not reveal any differences between SCA and the remaining NFA except for the higher recurrence rate of SCA. While steady-state PC1/3 mRNA levels determined by RT-PCR were almost comparable between SCAs and NFAs, immunohistochemical study showed negative immunostaining for PC1/3 in all 6 SCAs. Our data suggest that defective PC1/3 expression may lead to preferential production of unprocessed, biologically inactive ACTH variants in SCA.
Insights
Silent corticotroph adenoma (SCA) involves ACTH-producing pituitary tumors. Reduced prohormone convertase 1/3 (PC1/3) expression in SCAs may cause inactive ACTH production, explaining their unique clinical presentation.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Silent corticotroph adenoma (SCA) is an ACTH-producing pituitary tumor lacking Cushing's syndrome features.
- The molecular mechanisms underlying SCA development and function remain largely unknown.
Purpose of the Study:
- To investigate the role of prohormone convertase 1/3 (PC1/3) in the pathogenesis of SCAs.
- To test the hypothesis that reduced PC1/3 expression leads to the production of inactive ACTH precursors.
Main Methods:
- Immunohistochemical analysis of 30 non-functioning pituitary adenomas (NFAs), identifying 6 SCAs.
- Assessment of PC1/3 messenger RNA (mRNA) levels using RT-PCR.
- Immunohistochemical staining for PC1/3 in identified SCAs and NFAs.
Main Results:
- No significant differences in preoperative endocrine tests or imaging between SCAs and NFAs, except for a higher recurrence rate in SCAs.
- Steady-state PC1/3 mRNA levels were comparable between SCAs and NFAs.
- Immunohistochemistry revealed a complete absence of PC1/3 staining in all 6 SCAs.
Conclusions:
- Defective PC1/3 expression in SCAs likely results in the preferential production of unprocessed, biologically inactive ACTH variants.
- This finding provides insight into the molecular basis of silent corticotroph adenomas.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Huntington Disease l: Introduction
Caspases

